JENNIFER BAUM: Open Payments
NPI 1922264183 · ATCHISON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 12 payments from 8 companies in 2025. Trend: 2023 $61 · 2024 $134 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Lilly USA, LLC | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| ABBVIE INC. | 1 | $27 |
| Electromed, Inc. | 1 | $15 |
| SANOFI PASTEUR INC. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| Solventum Corporation | 1 | $14 |
Products named: CAPLYTA, JARDIANCE, LEQVIO, QULIPTA, SMARTVEST, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, OTEZLA, ACTIV.A.C..
Industry payments across KS — which companies pay providers there.
